Bluestein Ventures — Activity | F4Bluestein Ventures Activity
Every public signal F4 has attached to this firm, with sources and cross-entity links.
News
Bluestein Ventures hosted its Fourth Annual Investor Summit featuring founders and fund updates.
Fourth Annual Investor Summit
Ashley Hartman was recognized on Ingeborg's Healthcare Power Investor List.
Ashley Hartman — Ingeborg Healthcare Power Investor List
Milestone
Portfolio company Provi surpassed $5B in GMV flowing through its beverage distribution platform.
Provi
Talk
Andrew Bluestein moderated a panel on the Future of the Microbiome at HLTH USA.
HLTH USA — Future of the Microbiome Panel
Investment
BiomeSense closed an oversubscribed $7M round for its gut microbiome research and testing platform.
BiomeSense
Investment
ALTR secured a $5M seed round and was featured in Forbes.
ALTR
Milestone
Crafty Delivers announced a major strategic partnership with Staples.
Crafty
Investment
Lembas Bio, a GLP-1 ingredient manufacturer, entered the market following a $3.6M pre-seed investment.
Lembas Bio
Investment
Crafty Delivers secured a $10M funding round through a partnership with JLL and JLL Spark Global Ventures.
Crafty
Team Change
Former RXBAR CMO Lindsay Levin joined Bluestein Ventures as Venture Partner alongside the Fund III close.
Lindsay Levin joins as Venture Partner
New Fund
Bluestein Ventures closed Fund III at $45M to invest in nutrition, sustainability, and digitization across the food value chain.
Fund III — $45M